U.S. Professional Services Stock News

Corebridge Financial stock: recent performance snapshot Corebridge Financial (CRBG) has drawn attention after recent share price weakness, with the stock showing negative returns over the past month, past 3 months and year to date, prompting investors to reassess its risk and return trade off. See our latest analysis for Corebridge Financial. At a share price of US$22.30, Corebridge Financial has seen momentum fade recently, with a 30 day share price return of 13.70% decline and a 1 year...

United Therapeutics reported positive phase 3 results from its TETON-1 study of nebulized Tyvaso in idiopathic pulmonary fibrosis (IPF). The trial met its primary efficacy endpoint and showed significant benefits over placebo with a favorable safety profile. The company plans to seek a supplemental FDA approval to add IPF to the Tyvaso label, supported by integrated data from TETON-1 and TETON-2. For investors watching United Therapeutics, ticker NasdaqGS:UTHR, this news arrives with the...

Wondering if Atlanta Braves Holdings at around US$41.53 is offering good value or just a fan premium? This breakdown is designed to help you see what the current price really represents. The stock has seen a 1% decline over the last 7 days and a 5% decline over the last 30 days, while still showing returns of 4.2% year to date, 3.8% over 1 year, 23.2% over 3 years and 43.2% over 5 years. Recent coverage has focused on the company as a way to gain exposure to a well known sports franchise...

Christopher Hogbin, CEO of Asset Management at Lazard, recently exercised a sizable block of stock options. Following the exercise, he sold a significant portion of common shares, reducing his direct shareholdings. Hogbin still holds a large position in Lazard through outstanding restricted stock units, keeping meaningful exposure to NYSE:LAZ. Lazard, traded on the NYSE under ticker NYSE:LAZ, last closed at $39.11. The share price reflects a 22.7% decline over the past 30 days and a 21.4%...

Wondering if Clearwater Analytics Holdings at around US$23.49 is offering good value right now, or if the price already reflects most of the upside you care about. The stock has been relatively steady in the near term, with a 0.9% return over the last 7 days and 0.4% over the last 30 days, while year to date it shows a 2.6% decline and the 1 year return sits at a 12.4% decline, compared with a 48.6% gain over 3 years. Recent coverage has focused on Clearwater Analytics Holdings as a listed...

With no single headline event driving attention today, JBS (NYSE:JBS) is drawing interest as investors look at its recent share moves and its sizeable global meat processing footprint across beef, pork, poultry, and prepared foods. See our latest analysis for JBS. JBS’s recent 7 day share price return of 13.01% and 90 day share price return of 17.53%, with the stock now at $17.03, suggest momentum has picked up after a quieter 30 day share price return of 0.83%. If the JBS move has you...

Hawaiian Electric Industries (NYSE:HE) has agreed to a $100 million settlement to resolve significant stockholder derivative lawsuits. The payment will be funded by insurers and also partially settles a related securities class action. The agreement is subject to final court approval, with upcoming hearings expected to clarify the remaining legal process. For shareholders watching NYSE:HE at a current share price of $14.67, this settlement addresses a key source of legal uncertainty. The...

If you are wondering whether Viavi Solutions at US$34.64 is still attractively priced after a big run, the key question is what that price actually reflects about the business. The stock has delivered returns of 3.1% over the past week, 16.6% over the past month, 90.9% year to date and 209.6% over the last year, with a 225.3% return over three years and 114.0% over five years, which puts recent valuation questions front and center. Recent coverage has focused on Viavi Solutions as a...

Palvella Therapeutics (NasdaqCM:PVLA) has appointed Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services. McDonough has extensive experience launching and commercializing therapies for rare skin diseases, including work on VYJUVEK®. The appointment is intended to support Palvella’s commercial readiness as QTORIN™ rapamycin advances through late-stage trials. For investors watching rare disease drug developers, Palvella Therapeutics sits at the intersection of...

If you are wondering whether Cal-Maine Foods at around US$77.12 is pricing in too much optimism or leaving some value on the table, a closer look at its valuation can help frame that question. The share price is near US$77.12 after a 0.1% move over the last 7 days, with an 11.5% decline over 30 days, a 1.7% decline year to date, a 7.8% decline over 1 year, but a 53.8% gain over 3 years and a 159.0% gain over 5 years. Recent coverage has focused on Cal-Maine Foods as a key player in the US...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Morningstar...

Burford Capital recently reported that the US Court of Appeals for the Second Circuit reversed the prior District Court judgment in favor of Petersen and Eton Park in the long-running YPF litigation, prompting the company to review the case’s carrying value and consider a potentially material asset write-down in its upcoming first-quarter results. This reversal directly affects a case that represents a large share of Burford’s fair value assets, underscoring how concentrated legal exposures...

AnaptysBio has approved the spin off of First Tracks Biotherapeutics, with shareholders set to receive one First Tracks share for each AnaptysBio share held. First Tracks Biotherapeutics is expected to list on Nasdaq and will be funded through capital from AnaptysBio and a private placement. The company has added experienced industry executive Susannah Gray to its board as part of the transition. The spin off comes as AnaptysBio, listed as NasdaqGS:ANAB, is in focus with a current share...

Over the last 7 days, the United States market has experienced a 1.9% decline, yet it remains up by 15% over the past year with anticipated earnings growth of 15% annually in the coming years. In this dynamic environment, identifying promising small-cap stocks with insider buying can offer unique opportunities for investors seeking potential value amidst fluctuating market conditions.

Over the last 7 days, the United States market has dropped 1.9%, yet it has risen by 15% over the past year, with earnings forecast to grow annually by the same percentage. In this context of fluctuating short-term performance and promising long-term growth prospects, identifying high-growth tech stocks can be a strategic approach for investors looking to capitalize on innovation-driven sectors.

Over the last 7 days, the United States market has experienced a 1.9% decline, yet it remains up by 15% over the past year with earnings projected to grow by 15% annually. In such conditions, identifying stocks that may be trading below their intrinsic value can present potential opportunities for investors seeking to capitalize on undervalued assets in a growing market.

Over the last 7 days, the United States market has experienced a 1.9% decline, yet it remains up by 15% over the past year with earnings projected to grow by 15% annually. In this environment, identifying growth companies with high insider ownership can be advantageous as they often signal confidence in long-term prospects and alignment of interests between management and shareholders.

Over the last 7 days, the United States market has dropped 1.9%, while showing a notable 15% rise over the past year, with earnings expected to grow annually by the same percentage. In such a fluctuating market, identifying stocks with strong fundamentals and growth potential becomes crucial for investors seeking stability and opportunity. Penny stocks, though an older term, still signify smaller or emerging companies that can offer significant value; when these companies have solid...

Icahn Enterprises (IEP) has drawn fresh attention after recent trading left the units at a last close of US$7.45, with returns mixed across recent periods and a value score of 4 catching investor interest. See our latest analysis for Icahn Enterprises. Recent trading has been soft, with a 1 day share price return of 2.74% and a 30 day share price return of 7.57%. The 1 year total shareholder return of 3.47% contrasts with a 3 year total shareholder return of 72.93% and a 5 year total...

The United States market has experienced a 1.9% decline over the last week, yet it remains up by 15% over the past year, with earnings projected to grow annually by 15%. In this dynamic environment, identifying stocks like Seneca Foods that offer unique value propositions and growth potential can be key to uncovering hidden opportunities.

Over the last 7 days, the United States market has experienced a 1.9% drop, although it has risen by 15% over the past year with earnings expected to grow annually by the same percentage. In this fluctuating environment, dividend stocks can offer stability and income potential for investors seeking consistent returns amidst market volatility.

Palo Alto Networks, Inc. ( NASDAQ:PANW ) shareholders (or potential shareholders) will be happy to see that the...

The Morning Bull - US Market Morning Update Monday, Mar, 30 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 contracts up about 0.5%, as investors weigh rising government bond yields against mixed signals on consumer confidence. The US 10 year yield sits near 4.4%, which means borrowing costs for mortgages, credit cards and companies remain relatively expensive. At the same time, the University of Michigan consumer sentiment index is revised down to 53.3, while...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...